Consonance Capital Management as of Sept. 30, 2016
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 23 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Clovis Oncology | 12.2 | $127M | 3.5M | 36.05 | |
| Ariad Pharmaceuticals | 11.5 | $119M | 8.7M | 13.69 | |
| Mallinckrodt Pub | 10.5 | $109M | 1.6M | 69.76 | |
| United Therapeutics Corporation (UTHR) | 9.3 | $97M | 819k | 118.08 | |
| Amarin Corporation (AMRN) | 7.6 | $79M | 25M | 3.19 | |
| Retrophin | 6.7 | $69M | 3.1M | 22.38 | |
| Horizon Pharma | 6.5 | $67M | 3.7M | 18.13 | |
| Akorn | 5.8 | $60M | 2.2M | 27.26 | |
| Ironwood Pharmaceuticals (IRWD) | 5.0 | $52M | 3.3M | 15.88 | |
| Mednax (MD) | 4.2 | $44M | 660k | 66.25 | |
| Biosante Pharmaceuticals (ANIP) | 4.2 | $43M | 653k | 66.35 | |
| Globus Med Inc cl a (GMED) | 4.0 | $42M | 1.9M | 22.57 | |
| Merrimack Pharmaceuticals In | 3.6 | $38M | 6.0M | 6.35 | |
| Orthofix International Nv Com Stk | 2.6 | $27M | 635k | 42.77 | |
| Myriad Genetics (MYGN) | 1.7 | $18M | 850k | 20.57 | |
| eHealth (EHTH) | 1.2 | $13M | 1.2M | 11.21 | |
| HealthStream (HSTM) | 0.9 | $9.4M | 341k | 27.60 | |
| Adma Biologics (ADMA) | 0.9 | $9.2M | 1.3M | 7.24 | |
| Vericel (VCEL) | 0.6 | $6.3M | 2.2M | 2.80 | |
| AtriCure (ATRC) | 0.3 | $3.7M | 232k | 15.81 | |
| Biolase Technology | 0.3 | $3.1M | 1.8M | 1.75 | |
| Seaspine Holdings | 0.3 | $2.7M | 263k | 10.11 | |
| Veracyte (VCYT) | 0.1 | $1.3M | 166k | 7.61 |
